TSOI JadiCells COVID-19 must read $$$$$coming JadiCells were found to be safe and show early evidence of effectiveness in COVID-19 patients who were on ventilation at a hospital’s intensive care unit. The U.S. Food and Drug Administration subsequently cleared the company to start a pivotal Phase 3 clinical trial in people with COVID-19 and associated lung failure. https://copdnewstoday.com/2021/09/02/therapeutic-solutions-patent-jadicells-copd-stem-cell-therapy/